# Symptom tracking made simple? Observational data on the clinical use of the PERS2ON score in cancer patients receiving palliative care

## TL;DR

The PERS2ON score is a simple tool for tracking symptoms in cancer patients receiving palliative care, showing effectiveness in a rural hospital setting.

## Contribution

The study demonstrates the practical use of the PERS2ON score in real-world palliative care settings, particularly in rural hospitals.

## Key findings

- The PERS2ON score decreased significantly from admission to discharge, indicating symptom improvement.
- The tool was feasible to implement and allowed consistent symptom monitoring in a rural hospital.
- Scores showed a statistically significant reduction after 7 days and at discharge.

## Abstract

A standardized assessment of symptoms is essential for individualized palliative care (PC). While numerous tools exist, many are too complex for daily clinical use.

The PERS2ON score was developed as a brief and practical tool to assess symptom burden in PC. This study aimed to evaluate its feasibility in a rural hospital setting, although it did not include formal feasibility metrics such as recruitment or adherence rates.

Patients admitted to the palliative care unit of a rural hospital were assessed using the PERS2ON score, which includes seven items: pain, eating, rehabilitation, social situation, suffering, oxygen/dyspnea, and nausea/emesis. Each item is scored from 0 to 10, with higher scores indicating greater burden. Assessments were conducted on admission, after 7 days, and at discharge. Symptom scores were analyzed for change over time.

Of 60 admitted patients, 40 met the inclusion criteria. Reassessment was possible in 35 patients after 7 days and in 31 patients at discharge. The mean PERS2ON score decreased from 28 (SD 12) on admission to 21 (SD 11) after 7 days (difference: 7, 95% confidence interval, CI: 3–11, p = 0.002), and to 17 (SD 10) at discharge (difference: 11, 95% CI: 6–15, p < 0.001).

The PERS2ON score was feasible to implement and enabled consistent symptom monitoring. Its use may support structured clinical assessment and targeted symptom management even in smaller or rural palliative care units.